中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
THE CHINESE JOURNAL OF CLINICAL PHARMACOLOGY
2015年
12期
1095-1098
,共4页
张忠臣%吴丽丽%陈霞%陈玲玲%王国平%颜海帆
張忠臣%吳麗麗%陳霞%陳玲玲%王國平%顏海帆
장충신%오려려%진하%진령령%왕국평%안해범
前列地尔%2型肝肾综合征%肾血流%血管活性物质
前列地爾%2型肝腎綜閤徵%腎血流%血管活性物質
전렬지이%2형간신종합정%신혈류%혈관활성물질
alprostadil%type 2 hepatorenal syndrome%renal hemodynamics%vasoactive substance
目的:评价前列地尔对2型肝肾综合征( HRS)患者肾血流、血管活性物质的影响。方法入选86例2型肝肾综合征患者并随机分成试验组和对照组,各43例,对照组给予保肝、护肾、利尿等常规治疗;试验组在对照组基础上给予前列地尔注射液10μg,加入0.9%氯化钠注射液中,每日1次,2组疗程均为2周。比较2组治疗前后肾血流、血管活性物质及肝肾功能指标。结果治疗后,试验组搏动指数、阻力指数、收缩期最高峰值、舒张期最低峰值、一氧化氮、肾素、内皮素、谷丙转氨酶、总胆红素、血肌酸酐及尿素氮均低于对照组( P<0.05);试验组内生肌酐清除率显著高于对照组( P<0.05)。结论前列地尔可有效改善2型肝肾综合征患者肾血流和血管活性物质水平,提高临床疗效。
目的:評價前列地爾對2型肝腎綜閤徵( HRS)患者腎血流、血管活性物質的影響。方法入選86例2型肝腎綜閤徵患者併隨機分成試驗組和對照組,各43例,對照組給予保肝、護腎、利尿等常規治療;試驗組在對照組基礎上給予前列地爾註射液10μg,加入0.9%氯化鈉註射液中,每日1次,2組療程均為2週。比較2組治療前後腎血流、血管活性物質及肝腎功能指標。結果治療後,試驗組搏動指數、阻力指數、收縮期最高峰值、舒張期最低峰值、一氧化氮、腎素、內皮素、穀丙轉氨酶、總膽紅素、血肌痠酐及尿素氮均低于對照組( P<0.05);試驗組內生肌酐清除率顯著高于對照組( P<0.05)。結論前列地爾可有效改善2型肝腎綜閤徵患者腎血流和血管活性物質水平,提高臨床療效。
목적:평개전렬지이대2형간신종합정( HRS)환자신혈류、혈관활성물질적영향。방법입선86례2형간신종합정환자병수궤분성시험조화대조조,각43례,대조조급여보간、호신、이뇨등상규치료;시험조재대조조기출상급여전렬지이주사액10μg,가입0.9%록화납주사액중,매일1차,2조료정균위2주。비교2조치료전후신혈류、혈관활성물질급간신공능지표。결과치료후,시험조박동지수、조력지수、수축기최고봉치、서장기최저봉치、일양화담、신소、내피소、곡병전안매、총담홍소、혈기산항급뇨소담균저우대조조( P<0.05);시험조내생기항청제솔현저고우대조조( P<0.05)。결론전렬지이가유효개선2형간신종합정환자신혈류화혈관활성물질수평,제고림상료효。
Objective To explore the effect of alprostadil on renal hemodynamics and vasoactive substance in patients with type 2 hepato-renal syndrome ( HRS ) .Methods Eighty -six patients with type 2 hepatorenal syndrome were randomly divided into the observation group ( n=43 ) and the control group( n=43).They all accepted the conventional treatment , but the patients in the observation group were given the treatment of alprostadil injection 10 μg put into 0.9% NaCl injection once a day. The treatment lasted for 2 weeks.The data of renal hemodynamics and vasoactive substance were compared between the two group after 2 weeks. Results After treatment, the data of leak diastolic velocity, resistive index, peak systolic velocity, pulsatile index, the renin, endothelin, nitric oxide, glutamic pyruvic transaminase, total bilirubin, and creatinine and urea nitrogen in the observation group were significantly lower than those in the control group ( P<0.05 ) , and the endogenous creatinine clearance rate were significantly higher than that in the control group ( P<0.05 ) .Conclusion Alprostadil could improve the clinical efficacy by improving renal hemodynamics and vasoactive substance in patients with type 2 hepatorenal syndrome.